First Bites: Complementary Feeding - A Global Network Cluster Randomized Controlled Trial

NCT01084109 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1236

Last updated 2013-11-25

No results posted yet for this study

Summary

The specific aims of this project is to determine the impact of a daily intake of one half ounce of lyophilized meat between 6-18 months of age (0.5 oz for 6-12 mo; 0.75 oz for 12-18 mo) on linear growth velocity, zinc and iron intakes and status, brain growth and neurocognitive development, and infectious disease morbidity in populations traditionally dependent on non-micronutrient fortified plant foods for complementary feeding.

Conditions

  • Complementary Feeding
  • Infant Growth

Interventions

OTHER

Lyophilized meat

Daily intake of one half ounce of lyophilized meat between 6-18 months of age (0.5 oz for 6-12 mo; 0.75 oz for 12-18 mo)

OTHER

Cereal

Daily intake of an equi-caloric fortified cereal as complementary feed from 6 to 18 months.

Sponsors & Collaborators

  • Kinshasa School of Public Health

    collaborator OTHER
  • University of Zambia

    collaborator OTHER
  • INCAP, Chiimaltenango, Guatemala

    collaborator UNKNOWN
  • Aga Khan University

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • University of North Carolina, Chapel Hill

    collaborator OTHER
  • University of Alabama at Birmingham

    collaborator OTHER
  • Drexel University

    collaborator OTHER
  • RTI International

    collaborator OTHER
  • NICHD Global Network for Women's and Children's Health

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Months
Max Age
4 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2010-04-30
Completion
2010-07-31

Countries

  • Guatemala
  • Pakistan
  • Republic of the Congo
  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084109 on ClinicalTrials.gov